ONCY

Oncolytics Biotech
ONCY

Overview Fund Activity

46 hedge funds and large institutions have $1.21M invested in Oncolytics Biotech in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
$90K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
$59.7K
3
IAIM
International Assets Investment Management
Florida
$186K
4
Geode Capital Management
Geode Capital Management
Massachusetts
$61.2K
5
Goldman Sachs
Goldman Sachs
New York
$92.7K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
$0
2
LFCM
Long Focus Capital Management
Puerto Rico
$0
3
TSS
Two Sigma Securities
New York
$0
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$58K
5
Osaic Holdings
Osaic Holdings
Arizona
$1.88K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
– -$1.78K -2,017 Closed
Bank of America
52
Bank of America
North Carolina
– -$1.57K -1,800 Closed
1 2
3